196 related articles for article (PubMed ID: 34330094)
1. Trends in physician reimbursements and procedural volumes for radiosurgery versus open surgery in brain tumor care: an analysis of Medicare data from 2009 to 2018.
Lad M; Gupta R; Raman A; Parikh N; Gupta R; Chandra A; Para A; Aghi MK; Moore J
J Neurosurg; 2022 Jan; 136(1):97-108. PubMed ID: 34330094
[TBL] [Abstract][Full Text] [Related]
2. Trends in Medicare reimbursement for neurosurgical procedures: 2000 to 2018.
Haglin JM; Richter KR; Patel NP
J Neurosurg; 2019 Feb; 132(2):649-655. PubMed ID: 30717049
[TBL] [Abstract][Full Text] [Related]
3. The evolution of stereotactic radiosurgery in neurosurgical practice.
Trifiletti DM; Ruiz-Garcia H; Quinones-Hinojosa A; Ramakrishna R; Sheehan JP
J Neurooncol; 2021 Feb; 151(3):451-459. PubMed ID: 33611711
[TBL] [Abstract][Full Text] [Related]
4. Procedure Reimbursement, Inflation, and the Declining Buying Power of the Vascular Surgeon (2011-2021).
Haglin JM; Edmonds VS; Money SR; Davila VJ; Stone WM; Soh IY; Meltzer AJ
Ann Vasc Surg; 2021 Oct; 76():80-86. PubMed ID: 33901616
[TBL] [Abstract][Full Text] [Related]
5. Trends in laboratory test volumes for Medicare Part B reimbursements, 2000-2010.
Shahangian S; Alspach TD; Astles JR; Yesupriya A; Dettwyler WK
Arch Pathol Lab Med; 2014 Feb; 138(2):189-203. PubMed ID: 23738761
[TBL] [Abstract][Full Text] [Related]
6. Assessment of costs in open surgery and stereotactic radiosurgery for vestibular schwannomas.
Abou-Al-Shaar H; Azab MA; Karsy M; Guan J; Alzhrani G; Gozal YM; Jensen RL; Couldwell WT
J Neurosurg; 2018 Oct; 131(2):561-568. PubMed ID: 30485235
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
[TBL] [Abstract][Full Text] [Related]
8. Comparing the cost-effectiveness of two brain metastasis treatment modalities from a payer's perspective: stereotactic radiosurgery versus surgical resection.
Vuong DA; Rades D; van Eck AT; Horstmann GA; Busse R
Clin Neurol Neurosurg; 2013 Mar; 115(3):276-84. PubMed ID: 22705458
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases.
Lester-Coll NH; Dosoretz AP; Magnuson WJ; Laurans MS; Chiang VL; Yu JB
J Neurosurg; 2016 Dec; 125(Suppl 1):18-25. PubMed ID: 27903191
[TBL] [Abstract][Full Text] [Related]
10. Changing practice patterns of Gamma Knife versus linear accelerator-based stereotactic radiosurgery for brain metastases in the US.
Park HS; Wang EH; Rutter CE; Corso CD; Chiang VL; Yu JB
J Neurosurg; 2016 Apr; 124(4):1018-24. PubMed ID: 26473783
[TBL] [Abstract][Full Text] [Related]
11. An Analysis of Medicare Reimbursement for Neurosurgeon Office Visits: 2010 Compared to 2018.
Harrington MT; Pollock JR; Haglin JM; Richter KR; Patel NP
Neurosurgery; 2021 Jun; 89(1):E42-E48. PubMed ID: 34000736
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the drivers of cost of management when patients with brain metastases are treated with upfront radiosurgery.
Shenker RF; McTyre ER; Taksler GB; D'Agostino RB; Cramer CK; Ruiz J; Alphonse-Sullivan NK; Farris M; Watabe K; Xing F; Laxton AW; Tatter SB; Chan MD
Clin Neurol Neurosurg; 2019 Jan; 176():10-14. PubMed ID: 30468997
[TBL] [Abstract][Full Text] [Related]
13. Medicare Reimbursement Trends for Facility Performed Otolaryngology Procedures: 2000-2019.
Dominguez JL; Ederaine SA; Haglin JM; Aragon Sierra AM; Barrs DM; Lott DG
Laryngoscope; 2021 Mar; 131(3):496-501. PubMed ID: 32619309
[TBL] [Abstract][Full Text] [Related]
14. The cost effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors.
Rutigliano MJ; Lunsford LD; Kondziolka D; Strauss MJ; Khanna V; Green M
Neurosurgery; 1995 Sep; 37(3):445-53; discussion 453-5. PubMed ID: 7501109
[TBL] [Abstract][Full Text] [Related]
15. Medicare Utilization and Reimbursement for Vertebroplasty and Kyphoplasty: A National Analysis From 2012-2017.
Lopez CD; Boddapati V; Lombardi JM; Cerpa MK; Lee NJ; Mathew J; Sardar ZM; Lenke LG; Lehman RA
Spine (Phila Pa 1976); 2020 Dec; 45(24):1744-1750. PubMed ID: 32925685
[TBL] [Abstract][Full Text] [Related]
16. The cost-effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of brain metastasis in Vietnam from the perspective of patients and families.
Vuong DA; Rades D; Le AN; Busse R
World Neurosurg; 2012 Feb; 77(2):321-8. PubMed ID: 22120377
[TBL] [Abstract][Full Text] [Related]
17. Recent Trends in Medicare Utilization and Reimbursement for Spinal Cord Stimulators: 2000-2019.
Romaniuk M; Mahdi G; Singh R; Haglin J; Brown NJ; Gottfried O
World Neurosurg; 2022 Oct; 166():e664-e671. PubMed ID: 35872133
[TBL] [Abstract][Full Text] [Related]
18. Trends in Neurosurgical Practice Size: Increased Consolidation 2014-2019.
Singh R; Richter KR; Pollock JR; Haglin JM; Balli N; Catapano JS; Zimmerman RS; Patel NP
World Neurosurg; 2021 May; 149():e714-e720. PubMed ID: 33540094
[TBL] [Abstract][Full Text] [Related]
19. Bundled Medicare Payments: Trends in Utilization and Physician Payments for Dialysis Arteriovenous Fistula and Graft Maintenance Procedures From 2010 to 2018.
Lindquester WS; Dhangana R; Warhadpande S
AJR Am J Roentgenol; 2020 Oct; 215(4):785-789. PubMed ID: 32783553
[No Abstract] [Full Text] [Related]
20. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
